MARCELO MARIN: Open Payments
NPI 1730582800 · ENGLEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,143 in 216 payments from 19 companies in 2025. Trend: 2023 $4,075 · 2024 $3,493 · 2025 $3,143
Food & beverage: $2,999Education: $111Speaker / faculty: $33
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 53 | $718 |
| PFIZER INC. | 28 | $377 |
| ABBVIE INC. | 26 | $332 |
| Axsome Therapeutics, Inc. | 19 | $328 |
| Lundbeck LLC | 18 | $296 |
| Neurocrine BioSciences, Inc. | 17 | $267 |
| MDD US Operations, LLC | 17 | $199 |
| ACADIA Pharmaceuticals Inc | 8 | $120 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $116 |
| Novartis Pharmaceuticals Corporation | 5 | $82 |
Products named: AUSTEDO XR, NURTEC ODT, VYEPTI, Symbravo, INGREZZA, UBRELVY, Apokyn, NUPLAZID.
Industry payments across NJ — which companies pay providers there.
